PapersPMID:25015735
Postprandial glucose-lowering effects of fermented red ginseng in subjects with impaired fasting glucose or type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.
- findings
- 5
- compound
- 1
- endpoints
- 5
- Study, every finding
- RCT · 42 participants · 4 weeks
- Dose studied, every finding
- three FRG capsules per day (2.7 g per day) for four weeks
- Population, every finding
- Adults aged 20 to 75 years with impaired fasting glucose, impaired glucose tolerance or newly diagnosed type 2 diabetes (fasting glucose 5.6 to 7.8 mmol/l) not on glucose-lowering drugs, intention-to-treat
No finding here moved its endpoint.
What did not
How to read these marks →“After four weeks of supplementation, there were no significant differences in total cholesterol, HDL-cholesterol, LDL-cholesterol, or triglyceride levels between the FRG and placebo groups (Table 4).”
“The fasting plasma glucose level was significantly reduced by FRG supplementation (p = 0.039), but did not show a treatment effect when compared to the placebo group.”
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Adults aged 20-75 years with impaired fasting glucose, impaired glucose tolerance or type 2 diabetes (not on glucose-lowering therapy); fermented red ginseng extract of Panax ginseng C.A. Meyer (steamed, ethanol-extracted, fermented with Lactobacillus plantarum)
- Participants
- 42
- Comparator
- placebo
- Duration
- 28 days
- Endpoints measured
- 13